Peptide Field Book

Reading settings

Choose a comfortable text size and appearance. Your choices are saved on this device.

NAD+

Taken for energy and healthy aging

Nicotinamide adenine dinucleotide, not a peptide

Match every finding to its exact substance, formulation, route and study population. A related molecule or approved medicine does not validate a catalog vial.

Unresolved sources · Animal / laboratory evidence · Mechanistic / indirect records · Human / product-specific records
Schematic illustration · View structure evidence

Small molecule, not a peptide

At a glance

Why people take it. And what backs it up.

  1. Boost energy

    People report it, not studied

    The most common use: shots or IV drips to feel more energetic and less run-down.

    Sources (3)
  2. Slow aging

    People report it, not studied

    Longevity clinics sell drips and shots to restore NAD+ levels that fall with age; animal anti-aging studies used oral precursors, not NAD+.

    Sources (4)
  3. Clear brain fog

    People report it, not studied

    People take it, often as an IV drip, hoping for sharper focus and less brain fog.

    Sources (2)
  4. Support addiction recovery

    Clinic claims; no controlled trials

    Detox clinics run IV drips hoping to ease withdrawal and cravings during recovery from drugs or alcohol.

    Sources (4)

Evidence briefing

Sources checked

What the sources support.

NAD+ is a cellular coenzyme, not a peptide. The opened 2019 IV pilot randomized 11 healthy men: eight received NAD+ and three saline, with only short-term metabolite measurements. This is a small infusion study, not proof of anti-aging or clinical benefit. FDA has warned about food-grade NAD+ ingredients used in sterile injections and reports of severe chills, shaking, vomiting and fatigue consistent with endotoxin exposure. No FDA-approved NAD+ drug for wellness or longevity was identified.

Keep in mind

Results from oral NAD+ precursors such as NR/NMN do not establish benefit from infusing the native coenzyme; the IV evidence is sparse and product sterility/endotoxin quality is a separate serious concern.

Identity and research status reviewRead the original sources

The research. What’s been studied.

  • Human evidence

    Cellular energy chemistry

    NAD+ carries electrons in metabolic reactions that produce ATP; this normal biological role is not proof that supplementation increases energy or health in a person.

  • Animal & lab studies

    DNA-repair biology

    NAD+ is used by PARP enzymes in DNA-repair processes; a clinical benefit from NAD+ injections has not been established.

  • Animal & lab studies

    Sirtuin research

    Sirtuins use NAD+ and are studied in aging biology, mainly in experimental research; this does not show that NAD+ treatment slows human aging.

  • Early human studies

    Precursor studies

    Oral NR and NMN can raise some NAD-related blood measures in human studies, but they are not the same as IV NAD+ and health outcomes remain mixed.

What do these labels mean?
  • Human evidence: approved-drug data or larger human studies, within the populations and uses studied.
  • Early human studies: small, preliminary or limited human studies.
  • Animal & lab studies: animal or laboratory findings that do not establish effects in people.
  • Unverified: a proposed use or claim without verified supporting clinical evidence.
How each claim was reviewed (4)

Reported effects and evidence.

A citation may support, qualify or correct a claim. Read the study scope; a laboratory result is not an established benefit in people. Each review covers a claim as it was first collected; the tiles above show the collection’s current wording.

  1. Unknown — no direct primary source verified. Established endogenous biochemical role; supplementation inference unsupported

    Review of “Powers energy production”

    NAD+ is an endogenous metabolic cofactor; this biochemical role is not evidence that supplemental NAD+ improves vitality.

    Limitations and applicability. NAD+ being essential does not establish that administering additional NAD+ improves energy in people.

    Unknown: no direct primary source verified. This does not mean that no research exists.

    Original collected claim and review history

    Original title: Powers energy production

    Every cell needs NAD+ to turn food into ATP.

    Original label: proven. Preserved for traceability; the reviewed wording above qualifies this record.

    Record nad:benefit:1 · Annotated 2026-10-01 · Review method

  2. Preclinical endogenous NAD+ / DNA-repair mechanism

    Review of “Supports DNA repair”

    NAD+ participates in PARP1-related DNA-repair mechanisms; human benefit from administered NAD+ is unestablished by these experiments.

    Limitations and applicability. Mouse and molecular NAD+–PARP1 findings do not establish clinical DNA-repair benefits of injected NAD+.

    Original collected claim and review history

    Original title: Supports DNA repair

    Fuels PARP enzymes that repair damaged DNA.

    Original label: animal. Preserved for traceability; the reviewed wording above qualifies this record.

    Record nad:benefit:2 · Annotated 2026-10-01 · Review method

  3. Biochemical enzyme experiments

    Review of “Activates sirtuins”

    Sirtuin-family enzymes use NAD+; this molecular role does not establish a human anti-aging benefit from NAD+ products.

    Limitations and applicability. NAD dependence of sirtuin activity is not evidence that an NAD+ product extends human healthspan.

    Original collected claim and review history

    Original title: Activates sirtuins

    Sirtuins are proteins linked to healthy aging in animal studies.

    Original label: animal. Preserved for traceability; the reviewed wording above qualifies this record.

    Record nad:benefit:3 · Annotated 2026-10-01 · Review method

  4. Human oral precursor biomarker trials; formulation mismatch

    Review of “Restores falling levels”

    Oral NR trials raised blood NAD+ metabolites. Do not transfer that finding to injectable NAD+ or equate it with established healthy-aging benefit.

    Limitations and applicability. Oral NR/NMN are different interventions from infused/injected NAD+; higher blood biomarker levels are not proven health benefit.

    Original collected claim and review history

    Original title: Restores falling levels

    Levels drop with age; oral precursors (NR, NMN) reliably raise them in people, though health benefits are modest so far.

    Original label: early. Preserved for traceability; the reviewed wording above qualifies this record.

    Record nad:benefit:4 · Annotated 2026-10-01 · Review method

The research in detail

Evidence category

Small or older human studies

NAD+ is biologically essential, but that does not show that extra NAD+ improves health or slows aging. One small IV pilot enrolled 11 men, with eight receiving NAD+ and three saline, and measured short-term blood and urine metabolites. Much human NAD research concerns oral precursors such as NR and NMN, which are different interventions. FDA has warned about food-grade NAD+ used in sterile injections and reported reactions consistent with exposure.

Evidence is assessed claim by claim above. Regulatory approval, study design, findings and relevance are separate questions; there is no single evidence score.

Risks and unknowns. What to know first.

Collected cautions follow. These are not an exhaustive or independently validated safety assessment; claim references do not automatically support every caution.

  • Given too fast, it causes nausea, cramping, chest tightness, flushing and headache.
  • Effects of long-term high dosing are unknown.

What people report

Show all 4 cautionsShow fewer cautions

Read this first: what “research use only” means

Published dosing records. What the trials used.

Historical label and trial records for the named product, route, population and indication. These records are not a personal schedule or a validated regimen for a catalog vial. Source attribution does not establish applicability.

6-hour infusion study

Small pilot study in healthy men tracking NAD+ in blood and urine during a long drip (Frontiers in Aging Neuroscience, 2019)

Given by a clinicianClinical trial

Source: Grant et al., Frontiers in Aging Neuroscience, 2019 (opens in a new tab)

Over 6 hours
750 mg
How
Into a vein (drip)
How often
One infusion, run over 6 hours
How long
A single 6-hour infusion
  • Eleven healthy men took part: 8 got NAD+ and 3 got a saltwater drip.
  • No side effects were seen during the infusions.
  • The authors picked the dose because it matched a common regimen at wellness clinics.
  • The drip ran at about 2 mg per minute.

Heart failure trial

Randomized, placebo-controlled trial in 180 adults with heart failure caused by coronary artery disease, on top of standard treatment (American Journal of Cardiovascular Drugs, 2026)

Given by a clinicianClinical trial

Source: Yu et al., American Journal of Cardiovascular Drugs, 2026 (opens in a new tab)

Days 1–7
10 mg
How
Into a vein (drip)
How often
Once a day
How long
7 days in the trial
  • Each dose was mixed into 100 mL of glucose or salt solution and dripped in over about 40–60 minutes.
  • The NAD+ product used carries a Chinese drug approval number.
  • Drip rate no faster than 200 mL per hour.

Hearing-loss trial

Small randomized trial in 38 people treated in hospital for sudden hearing loss, on top of standard treatment (The Laryngoscope, 2026)

Given by a clinicianClinical trial

Source: Gao et al., The Laryngoscope, 2026 (opens in a new tab)

Each day in hospital
5 mg
How
Into a muscle
How often
Once a day
How long
During the hospital stay (median 7 days, range 4–13 days)
  • Each 5 mg dose was given in 2 mL of saltwater.
  • The comparison group got standard treatment only, with no placebo injection.

These doses were tested in clinical trials under medical supervision. They aren’t approved for use, and a research vial is not the product that was tested.

Community protocols. Reported online. Not clinically validated.

Community reports Collection date: 30 Sep 2026

NAD+ is used three main ways: injections under the skin at clinics or at home (usually 50–100 mg, one to three times a week, started at 20–50 mg because it causes flushing and discomfort); intravenous drips of about 250–1,000 mg run slowly over about 1.5–5 hours; and multi-day intravenous “detox” programs of 500–1,500 mg a day.

More about this

Nasal sprays range from about 25 mg to 120 mg a day.

Not testedFrequently encountered in reviewed sources

Injection under the skin (wellness / anti-aging)

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
50–100 mg per shot (started at 20–50 mg)
How often
Once a week up to three times a week
Route
Injection under the skin (belly, thigh or back of the arm)
How long
Ongoing; one clinic reviews the dose every 4 weeks
Ramp
50 mg once a week for 4 weeks, then 100 mg if tolerated (one clinic’s standard procedure); another clinic describes an optional loading phase of 100–200 mg daily for 7–10 days
Mixing
Compounded or research vials; at 200 mg/mL, 0.25 mL is about 50 mg and 0.5 mL about 100 mg
  • Started low because injections can cause flushing, cramping, nausea and injection-site pain.
Sources (4)

Not testedCommon

Intravenous drip at a clinic

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
About 250–1,000 mg per drip (500 mg is typical)
How often
Single sessions, or several days in a row (for example 4 daily 500 mg drips as a “loading” course)
Route
Drip into a vein (intravenous)
Timing
Run slowly; sessions last about 1.5–5 hours, and the drip is slowed when symptoms appear
Cycle
Some continue with a drip every 4–6 weeks (one case report)
Mixing
Mixed into a saline bag by clinic staff
  • Discomfort during the drip is so common that patients in one study set their own drip speed.
Sources (2)
Show all 7 protocolsShow fewer protocols

Not testedSometimes seen

Multi-day intravenous addiction or detox program (“BR+NAD”)

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
500–1,500 mg a day
How often
One drip a day
Route
Drip into a vein (intravenous)
Timing
Each drip over about 3–5 hours
How long
About 4–15 days in a row
Cycle
Some programs then taper to twice a week for a month, then twice a month
Ramp
Some start high (for example 1,500 mg on day 1) and step down
  • Sold for alcohol, opioid, benzodiazepine and methadone withdrawal, often with vitamin drips and other add-ons; programs cost thousands of dollars.
Sources (3)

Not testedSometimes seen

Nasal spray

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
About 25 mg a day (retail spray) up to 120 mg a day (compounded, in a case report)
How often
Once or twice a day
Route
Nasal
  • Retail sprays contain far less than compounded clinic sprays.
Sources (2)

Not testedSometimes seen

Pre-mixed with MOTS-c, or small twice-weekly shots

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
About 30–90 mg NAD+ per shot
How often
Once or twice a week
Route
Injection under the skin
Timing
Morning
Ramp
Stepped up gradually because of flushing
Mixing
Pre-mixed NAD+/MOTS-c vials (one: 20 units = 60 mg NAD+ + 0.5 mg MOTS-c)
Sources (2)

Not testedFringe

Injection into a muscle

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
25–50 mg to start, up to 100 mg
How often
Up to twice a week
Route
Into a muscle
  • Described as anecdotal, with no safety or effectiveness data.
Sources (1)

Not testedFringe

Oral NAD+

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
600 mg a day (one user)
How often
Daily
Route
Oral
  • A compounding-education review says oral NAD+ is generally not recommended because it is poorly absorbed.
Sources (1)

Where the numbers come from

The intravenous protocols trace largely to addiction-treatment clinics using the “BR+NAD” (Brain Restoration) approach linked to NAD Research, Inc., which a compounding-education review cites for its daily-drip loading courses. Injection doses are clinic convention, and published human evidence is mostly case reports.

Home-made sprays and serums

Home-made nasal spray. Community recipes. Not tested.

Original source recordsHide

NAD+ nasal sprays are sold by at least one US compounding pharmacy (Empower, 300 mg per mL) and by vendors (for example 1,000 mg per bottle, 10 mg per spray). Users report doses such as three 10 mg sprays a day, 20 mg a day, or one spray per nostril each morning. No home-made recipe was found. How much is absorbed is unknown.

Best evidence: Compounding pharmacy product (Empower Pharmacy, 503A, 15 mL, 300 mg per mL, refrigerated). Vendor products. Only animal research on intranasal NAD found (mouse smell-loss study, 2026); no human trials.

Not testedNasal sprayCommon

Ready-made vendor NAD+ sprays (for comparison)

Original source-specific report. Collection checked 30 Sep 2026; presentation annotated 2026-10-01. Source date and reporter identity are not separately verified. Exact form and route are limited to the source’s description.

Ingredients and methodHide the recipe

Ingredients

IngredientAmountRole
NAD+1,000 mg per bottle (10 mg per spray) or 500 mg per bottleActive
How it’s used
Reported: 3 sprays a day; 1 spray per nostril each morning; 20 mg a day.
Per dose
10 mg per spray (1,000 mg bottle, stated).
Sources (3)

Not testedNasal spraySometimes seen

Compounding pharmacy NAD+ nasal spray (Empower Pharmacy)

Original source-specific report. Collection checked 30 Sep 2026; presentation annotated 2026-10-01. Source date and reporter identity are not separately verified. Exact form and route are limited to the source’s description.

Batch: 15 mL

Ingredients and methodHide the recipe

Ingredients

IngredientAmountRole
NAD+300 mg per mLActive
How it’s used
As prescribed. Empower’s general nasal-spray instructions: blow your nose; prime until a fine mist appears; close one nostril and aim toward the back of the head, not the septum; wipe the nozzle and store upright.
Storage
Refrigerator, 2–8 °C; do not freeze; protect from light.
Keeps for
Discard after the pharmacy’s beyond-use date.
  • Listed as available through Empower’s 503A (prescription) pharmacy.

Not stated: the amount per dose.

Sources (4)

Not testedOtherFringe

Intranasal NAD in mice (reference, not a home recipe)

Original source-specific report. Collection checked 30 Sep 2026; presentation annotated 2026-10-01. Source date and reporter identity are not separately verified. Exact form and route are limited to the source’s description.

Ingredients and methodHide the recipe

Ingredients

IngredientAmountRole
NADdose not given in the abstractActive
How it’s used
Mice with chemically induced loss of smell.
Sources (1)
Editorial synthesis and reported strength comparison

This synthesized method combines source records. It has not been validated for preparation, sterility, compatibility, absorption or storage. Select a reported strength to inspect the arithmetic; no strength is selected for you.

Not testedNasal spray

No amounts were found in the reviewed recipe records for this one. What was found is under “Original source records”.

Good to know

  • Bacteriostatic water contains 0.9–1.1% benzyl alcohol as a preservative. Its label covers mixing injections, not nasal use; EU labels warn of allergic reactions.
  • Some use store-bought saline nasal spray for its preservatives: often benzalkonium chloride, which can irritate the nose with long use, and sometimes benzyl alcohol.
  • Never tap water: it is not sterile, and CDC researchers warn against it for nasal rinsing.
What people report

On the skin: home-made serums. Community recipes. Not tested.

Original source recordsHide

NAD+ is sold as a cosmetic ingredient for serums and creams. One supplier gives a use level of 0.5–1% and warns it breaks down with heat and alkaline pH. Users mention adding NAD+ to home-made peptide serums but give no amounts.

Best evidence: Supplier information only. No human topical studies of NAD+ itself were found.

Not testedSerumSometimes seen

Supplier use level for NAD+ in a serum or cream

Original source-specific report. Collection checked 30 Sep 2026; presentation annotated 2026-10-01. Source date and reporter identity are not separately verified. Exact form and route are limited to the source’s description.

Batch: per 100% (any batch size)

Ingredients and methodHide the recipe

Ingredients

Ingredient%Role
NAD+ (nicotinamide adenine dinucleotide) powder0.5–1%Active
Water-based serum or cream baseBase

Method

  1. Dissolve fully (the supplier suggests vortex mixing or a sonicator).
  2. Formulate at cool temperatures; NAD+ breaks down from about 38 °C and in alkaline pH.
Storage
Refrigerator; airtight, opaque packaging
  • A Reddit user planning an all-in-one serum with NAD+ was told NAD+ and glutathione degrade quickly in solution.

Not stated: how it’s used.

Sources (5)
Editorial synthesis and reported strength comparison

This synthesized method combines source records. It has not been validated for preparation, sterility, compatibility, absorption or storage. Select a reported strength to inspect the arithmetic; no strength is selected for you.

Not testedOn the skin

No amounts were found in the reviewed recipe records for this one. What was found is under “Original source records”.

Good to know

  • Use distilled water, not tap: tap water carries minerals, chlorine and microbes that can spoil the serum.
Research notes

NAD+ is not a peptide, and the evidence behind all of these protocols is thin. Clinic figures vary: one clinic’s standard procedure caps injections at 100 mg a week, while another clinic describes 100–200 mg daily loading. Home users often take NAD+ alongside several peptides and GLP-1 drugs.

Nasal spray

Empower lists its spray as 300 mg per mL, while vendor sprays are described per bottle or per spray without bottle volumes, so their strengths cannot be compared. No home-made NAD+ spray recipe was found (a 2025 ‘DIY’ question went unanswered). User claims of ‘20–40%’ nasal absorption are unsourced. The only intranasal NAD research found is in mice.

On the skin

Only one supplier’s use level was found. General web search engines were largely blocked during this research (captcha / degraded results), so a web-only product could have been missed.

What it is. In plain English.

A coenzyme involved in cellular energy reactions; evidence for wellness benefits from IV or injected NAD+ is very limited.

A molecule built from two nucleotides, made in the body from vitamin B3. “Buffered” means the pH is adjusted to reduce the sting of injection.

NAD+ carries electrons in the reactions that turn food into cellular energy (ATP). It’s also used up by DNA-repair enzymes (PARPs) and by sirtuins, proteins linked to aging. Tissue levels decline with age, which drives the interest in topping it up.

Reviewed 2026-10-01.

Structure. The same molecule, inside an enzyme.

, not measured

Computed 3D model of free NAD+ as balls and sticks: carbon atoms orange, phosphorus a deeper orange, nitrogen blue, oxygen red.

A computed model of free NAD+, on its own and not bound to any enzyme: a shape calculated from its atoms and bonds. Carbon atoms are orange, phosphorus a deeper orange, nitrogen blue and oxygen red; hydrogen atoms aren’t drawn. Its formula and bonds were checked against the molecule’s known structure.

Good to know

  • NAD+ is flexible, so this is only one of the shapes it can take.

PubChem CID 5892. Rendered with Mol* (Sehnal et al., 2021).

Specs. The facts at a glance.

Type
coenzyme
Sold as
  • NAD+ 250 mg buffered
  • NAD+ 500 mg buffered
Regulatory status
No FDA-approved NAD+ drug for wellness or longevity was identified. Clinics may offer compounded or other injectable products, but those are not FDA-approved treatments; FDA has warned about food-grade ingredients and endotoxin risks in sterile NAD+ injections.
Also known as
Nicotinamide adenine dinucleotide, not a peptide

Sources. What this page rests on.

Every source behind this page, with what it says and when it was checked, is in the Source library.

NAD+ in the Source library

Original overview and research notes · annotated 2026-10-01

Historical collection text. Read alongside the claim corrections above; identity or evidence qualifications may supersede this wording.

Cellular energy and healthy aging

A coenzyme every cell uses for energy, popular as an anti-aging injection or IV drip.

A molecule built from two nucleotides, made in the body from vitamin B3. “Buffered” means the pH is adjusted to reduce the sting of injection.

NAD+ carries electrons in the reactions that turn food into cellular energy (ATP). It’s also used up by DNA-repair enzymes (PARPs) and by sirtuins, proteins linked to aging. Tissue levels decline with age, which drives the interest in topping it up.

Boosting NAD+ in mice improves metabolism and some signs of aging. Human research mostly uses oral precursors (NR, NMN), which reliably raise blood NAD+ but have shown modest or mixed health benefits. Injected or IV NAD+ has very little controlled research.

Original status record: Not an approved drug for these uses; offered by wellness clinics and sold as a research chemical.

More in Longevity.

Glossary

Endotoxin

Fragments of bacterial cell walls that survive sterilization. Injected, they can cause fever, chills and serious inflammatory reactions.

Glossary

X-ray crystallography

Molecules are packed into a crystal and hit with X-rays; the pattern the rays make reveals where each atom sits.

Glossary

Resolution

How sharp a structure is, measured in ångströms (Å; a ten-billionth of a meter). Smaller is sharper.

Glossary

Protein Data Bank (PDB)

The free worldwide archive of 3D structures of proteins and other molecules measured in experiments. Each entry has a four-character code, like 7KI0.

Glossary

Computed model

A 3D shape calculated by software from a molecule’s atoms and bonds, not measured in an experiment.